Latham & Watkins advises Phathom Pharmaceuticals in pricing of US$130 million public offering of common stock. Phathom Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and...
Phathom Pharmaceuticals’ $130 Million Public Offering of Common Stock
Phathom Pharmaceuticals’ $260 Million Financing Agreement
Morgan Lewis advised Phathom Pharmaceuticals Inc. in the transaction. Phathom Pharmaceuticals Inc. announced a revenue interest financing agreement for $260 million in non-dilutive capital. The agreement provides...